Skip to main content

Table 4 Estimation of effective half-life, activity at infusion time, and corresponding local absorbed dose for volumes V1, V2, and V3

From: Tissue dose estimation after extravasation of 177Lu-DOTATATE

 

Effective half-life Teff (h)

A0 (MBq)

Estimated dose (Gy)

V1

2.39 ± 0.002

7471 ± 26

2.26 ± 0.07

V2

2.257 ± 0.002

5715 ± 20

4.07 ± 0.13

V3

2.256 ± 0.002

3592 ± 13

6.77 ± 0.22